Interstitial Lung Abnormalities and Aging Biomarkers: A Mediation

por Oldham, Justin M.
Publicado 2021

Fibrotic lung disease: A molecular glimpse into severe Covid-19?

por Spagnolo, Paolo, Oldham, Justin M
Publicado 2021

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker

por Spagnolo, Paolo, Oldham, Justin M.
Publicado 2022

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management

por Oldham, Justin M., Collard, Harold R.
Publicado 2017

Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response

por Bowman, Willis S., Echt, Gabrielle A., Oldham, Justin M.
Publicado 2021

Clinical Genetics in Interstitial Lung Disease

por Newton, Chad A., Molyneaux, Philip L., Oldham, Justin M.
Publicado 2018

In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs

por Alqalyoobi, Shehabaldin, Fernández Pérez, Evans R., Oldham, Justin M.
Publicado 2020

The prognostic value of gastroesophageal reflux disorder in interstitial lung disease related hospitalizations

por Alqalyoobi, Shehabaldin, Little, Bertis Brit, Oldham, Justin M., Obi, Ogugua Ndili
Publicado 2023

Reply to Noboa-Sevilla et al.

por Vu Pugashetti, Janelle, Newton, Chad A., Molyneaux, Philip L., Oldham, Justin M.
Publicado 2022

Reply to Lescoat et al. and to Khamis et al.

por Adegunsoye, Ayodeji, Oldham, Justin M., Sperling, Anne I., Noth, Imre, Strek, Mary E., Chung, Jonathan H.
Publicado 2019

Reply to Spek and Duitman

por Oldham, Justin M., Allen, Richard J., Lorenzo-Salazar, Jose M., Flores, Carlos, Wain, Louise V., Noth, Imre
Publicado 2023

Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis

por Kreuter, Michael, Lee, Joyce S., Tzouvelekis, Argyrios, Oldham, Justin M., Molyneaux, Philip L., Weycker, Derek, Atwood, Mark, Kirchgaessler, Klaus-Uwe, Maher, Toby M.
Publicado 2021

Autoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis

por Adegunsoye, Ayodeji, Oldham, Justin M., Husain, Aliya N., Chen, Lena, Hsu, Scully, Montner, Steven, Chung, Jonathan H., Vij, Rekha, Noth, Imre, Strek, Mary E.
Publicado 2017

Lung function trajectories in patients with idiopathic pulmonary fibrosis

por Neely, Megan L, Hellkamp, Anne S, Bender, Shaun, Todd, Jamie L, Liesching, Timothy, Luckhardt, Tracy R, Oldham, Justin M, Raj, Rishi, White, Eric S, Palmer, Scott M
Publicado 2023

Walking the path of treatable traits in interstitial lung diseases

por Amati, Francesco, Spagnolo, Paolo, Ryerson, Christopher J., Oldham, Justin M., Gramegna, Andrea, Stainer, Anna, Mantero, Marco, Sverzellati, Nicola, Lacedonia, Donato, Richeldi, Luca, Blasi, Francesco, Aliberti, Stefano
Publicado 2023

Acute exacerbations of progressive-fibrosing interstitial lung diseases

por Kolb, Martin, Bondue, Benjamin, Pesci, Alberto, Miyazaki, Yasunari, Song, Jin Woo, Bhatt, Nitin Y., Huggins, John T., Oldham, Justin M., Padilla, Maria L., Roman, Jesse, Shapera, Shane
Publicado 2018

T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival

por Bonham, Catherine A., Hrusch, Cara L., Blaine, Kelly M., Manns, Stephenie T., Vij, Rekha, Oldham, Justin M., Churpek, Matthew M., Strek, Mary E., Noth, Imre, Sperling, Anne I.
Publicado 2019

Diagnostic test interpretation and referral delay in patients with interstitial lung disease

por Pritchard, David, Adegunsoye, Ayodeji, Lafond, Elyse, Pugashetti, Janelle Vu, DiGeronimo, Ryan, Boctor, Noelle, Sarma, Nandini, Pan, Isabella, Strek, Mary, Kadoch, Michael, Chung, Jonathan H., Oldham, Justin M.
Publicado 2019

Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

por Podolanczuk, Anna J., Kim, John S., Cooper, Christopher B., Lasky, Joseph A., Murray, Susan, Oldham, Justin M., Raghu, Ganesh, Flaherty, Kevin R., Spino, Cathie, Noth, Imre, Martinez, Fernando J.
Publicado 2022

Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosis

por Oldham, Justin M., Johnson, Kirk W., Albers, Gesa J., Calamita, Emily, Mah, Jordina, Ghai, Poonam, Hewitt, Richard J., Maher, Toby M., Molyneaux, Philip L., Huang, Michael, Byrne, Adam J.
Publicado 2023